These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6778528)

  • 21. A study of acid beta-glucosidase in a patient with Gaucher disease and leukemia.
    Leibovitz-BenGershon Z; Rosenthal J; Shinar E
    Prog Clin Biol Res; 1982; 95():481-91. PubMed ID: 6812083
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic heterogeneity in type I Gaucher disease.
    Devine EA; Beighton P; Petersen EM; Desnick RJ
    Prog Clin Biol Res; 1982; 95():495-510. PubMed ID: 6812084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of glucocerebroside beta-glucosidase for entrapment in liposomes and treatment of patients with adult Gaucher's disease.
    Braidman I; Gregoriadis G
    Biochem Soc Trans; 1976; 4(2):259-61. PubMed ID: 1001662
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.
    Gatt S; Dinur T; Desnick RJ
    Prog Clin Biol Res; 1982; 95():315-31. PubMed ID: 6812076
    [No Abstract]   [Full Text] [Related]  

  • 25. Imino sugar therapy for type 1 Gaucher disease.
    Priestman DA; Platt FM; Dwek RA; Butters TD
    Glycobiology; 2000 Nov; 10(11):iv-vi. PubMed ID: 11221677
    [No Abstract]   [Full Text] [Related]  

  • 26. beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell.
    Newburg DS; Yatziv S; McCluer RH; Raghavan S
    Biochim Biophys Acta; 1986 Jun; 877(1):121-6. PubMed ID: 3087427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gaucher disease: a membranous enzymopathy.
    Desnick RJ; Grabowski GA; Dinur T; Fabbro D; Goldblatt J; Gatt S
    Prog Clin Biol Res; 1982; 97():193-215. PubMed ID: 6818558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
    Sawkar AR; Cheng WC; Beutler E; Wong CH; Balch WE; Kelly JW
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15428-33. PubMed ID: 12434014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased red blood cell aggregation in patients with Gaucher disease is non-inflammatory.
    Adar T; Ben-Ami R; Elstein D; Zimran P; Berliner S; Yedgar S; Barshtein G
    Clin Hemorheol Microcirc; 2008; 40(2):113-8. PubMed ID: 19029636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaucher type I (Ashkenazi) disease: considerations for heterozygote detection and prenatal diagnosis.
    Grabowski GA; Dinur T; Gatt S; Desnick RJ
    Prog Clin Biol Res; 1982; 95():573-95. PubMed ID: 6812087
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple forms of membrane-bound beta-glucosidase in human leucocytes.
    Carroll M
    Biochem Soc Trans; 1981 Feb; 9(1):129-30. PubMed ID: 6783452
    [No Abstract]   [Full Text] [Related]  

  • 33. Homozygote and heterozygote identification.
    Wenger DA; Roth S
    Prog Clin Biol Res; 1982; 95():551-72. PubMed ID: 6812086
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple forms of human skin fibroblast beta-glucosidase and their activation by fibroblast monosialoglycosphingolipids.
    Saito M; Mueller OT; Rosenberg A
    Prog Clin Biol Res; 1982; 95():385-403. PubMed ID: 6812078
    [No Abstract]   [Full Text] [Related]  

  • 35. Heterozygote detection of type I Gaucher disease using blood platelets.
    Nakagawa S; Kumin S; Sachs G; Nitowsky HM
    Prog Clin Biol Res; 1982; 95():597-602. PubMed ID: 6812088
    [No Abstract]   [Full Text] [Related]  

  • 36. Qualitative characteristics of the beta-glucosidase isozymes.
    Choy FY; Davidson RG
    Prog Clin Biol Res; 1982; 95():415-41. PubMed ID: 6812079
    [No Abstract]   [Full Text] [Related]  

  • 37. Soluble and membranous neutral beta-glucosidases.
    Ben-Yoseph Y; Nadler HL
    Prog Clin Biol Res; 1982; 95():465-80. PubMed ID: 6812082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced calcium release in the acute neuronopathic form of Gaucher disease.
    Pelled D; Trajkovic-Bodennec S; Lloyd-Evans E; Sidransky E; Schiffmann R; Futerman AH
    Neurobiol Dis; 2005 Feb; 18(1):83-8. PubMed ID: 15649698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes.
    Trajkovic-Bodennec S; Bodennec J; Futerman AH
    Blood Cells Mol Dis; 2004; 33(1):77-82. PubMed ID: 15223015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative properties of the three groups of splenic beta-glucosidase molecular forms.
    Salvayre R; Maret A; Negre A; Douste-Blazy L
    Prog Clin Biol Res; 1982; 95():443-52. PubMed ID: 6812080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.